Smith Group Asset Management, LLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1893134 DALLAS, TX

Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,675,035

+$1,949,116 QoQ

Shares Held

73,896

+236.6% QoQ

Ownership

0.227%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#63

of 279 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Smith Group Asset Management, LLC holds $3,961,580 across 3 Drug Manufacturers - Specialty & Generic names. COLL ranks #1 (67.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc This page	73,896	$2,675,035
2	PAHC	Phibro Animal Health Corp	25,407	$797,779
3	NBIX	Neurocrine Biosciences Inc	2,900	$488,766

All Filings in COLL

Export CSV

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,675,035	73,896	+236.6%	Shares	Sole	2026-08-03
2026-03-31	$725,919	21,951	+9.3%	Shares	Sole	2026-05-18
2025-12-31	$929,981	20,086	+2.5%	Shares	Sole	2026-02-10
2025-09-30	$685,384	19,588	+3.0%	Shares	Sole	2025-11-13
2025-06-30	$562,184	19,012	-0.4%	Shares	Sole	2025-07-31
2025-03-31	$569,687	19,085	+0.4%	Shares	Sole	2025-04-28
2024-12-31	$544,693	19,012	+1.0%	Shares	Sole	2025-01-23
2024-09-30	$727,359	18,824	+25.1%	Shares	Sole	2024-10-25
2024-06-30	$484,610	15,050	+0.6%	Shares	Sole	2024-07-31
2024-03-31	$580,747	14,960	0.0%	Shares	Sole	2024-04-30
2023-12-31	$460,468	14,960	+26.6%	Shares	Sole	2024-02-12
2022-03-31	$240,553	11,815	-41.8%	Shares	Sole	2022-05-05
2021-12-31	$379,241	20,302	-2.5%	Shares	Sole	2022-02-02
2021-09-30	$411,105	20,826	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.